1. Percentages of 256 clinical isolates obtained from immunocompetent and immunocompromised patients (HIV positive) and from patients with other risk factors per major molecular type, identified by URA5 RFLP analysis, PCR fingerprinting, or AFLP analysis, for which clinical data were available.
Percentages of 256 clinical isolates obtained from immunocompetent and immunocompromised patients (HIV positive) and from patients with other risk factors per major molecular type, identified by URA5 RFLP analysis, PCR fingerprinting, or AFLP analysis, for which clinical data were available. Other risk factors are alcoholism, corticosteroid use, disorder T immunity, diabetes, leukemia, systemic lupus erythematosus, transplant, and tumor.
Sharon C.-A. Chen et al. Clin. Microbiol. Rev. 2014; doi: /CMR